Evolution of the concepts of criteria for the diagnosis and epidemiology of metabolic syndrome

Close metadata

Recommended articles:

Clinical and epidemiological characteristics of bronchial asthma and chronic obstructive pulmonary disease incidence in Russia before and during the COVID-19 epidemy. Russian Journal of Preventive Medicine. 2024;(6):42-48

Associations between components of metabolic syndrome and cognitive impairment in patients with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):82-87

Preadolescent acne. Russian Journal of Clinical Dermatology and Venereology. 2024;(2):175-180

Epidemiology of acute poisoning in pediatric practice. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):58-66

Cerebral hemodynamic disorders in patients with schizophrenia with concomitant metabolic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):80-85

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Epidemiological features papillomatosis of the larynx in adults: a literature review. Russian Bulletin of Otorhinolaryngology. 2024;(2):66-70

Predictors of effective complex physiotherapy in patients with skin involution. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(1):13-20

Serum uric acid — a metabolic marker of non-alcoholic fatty liver disease. Russian Journal of Evidence-Based Gastroenterology. 2024;(2):36-42

Assessment of the condition of organs and tissues of the oral cavity in people with dentition defects against the background of metabolic syndrome. Stomatology. 2024;(3):31-38

The paper considers the epidemiological aspects of metabolic syndrome (MS) and criteria for its diagnosis. The authors analyze the prevalence of MS in foreign countries, in the Russian Federation, and its individual regions and outline the results of their own observations. The prevalence of MS and its components is shown to be related to gender, age, race, psychosocial factors, and used diagnostic criteria. It is concluded that the uniform international criteria for and definitions of MS should be used.

Keywords:

metabolic syndrome

epidemiology

diagnostic criteria

Authors:

Zhuravlev Iu.I.

Belgorodskiĭ gosudarstvennyĭ natsional'nyĭ issledovatel'skiĭ universitet

Tkhorikova V.N.

FGAOU VPO "Belgorodskiĭ gosudarstvennyĭ natsional'nyĭ issledovatel'skiĭ universitet"

List of references:

Mamedov M.N. Arterial'naya gipertoniya v ramkakh metabolicheskogo sindroma: osobennosti techeniya I printsipy medikamentoznoy terapii [Arterial hypertension in the framework of metabolic syndrome: peculiarities of the clinical course and principles of medicamental treatment]. Kardiologiya 2004; 44: 4: 95-100. [In Russ.].
Mamedov M.N. Metabolicheskiy sindrom: prakticheskie aspekty diagnostiki I lecheniya v ambulatornykh usloviyakh: posobie dlya vrachey [Metabolic syndrome: the practical aspects of diagnostics and treatment under conditions of outpatient facilities: the guidelines for practitioners]. M 2005. [In Russ.].
Butrova S.A. Ot epidemii ozhireniya k epidemii sakharnogo diabeta [From the epidemic of obesity to the epidemic of diabetes mellitus]. Mezhdunar endokrinol zhurn 2013; 2: 50.. Rezhim dostupa: www. mif-ua. com/archive/article/35699 (data obrashcheniya 24. 05. 2013). [In Russ.].
Zimmet P., Shaw G., Alberti G. Preventing type 2 diabetes and the dysmetabolic syndrome in the real word: a realistic view. Deabetic medicine 2003; 20 (9): 693-702.
Conti C.R. The metabolic syndrome: is it really a syndrome? Clin Cardiol 2006; 29: 12: 523-524.
Oganov R.G. Metabolicheskiy sindrom: put' ot nauchnoy kontseptsii do klinicheskogo diagnoza [Metabolic syndrome: from the scientific concept to the clinical diagnosis]. Vrach 2007; 3: 3-7. [In Russ.].
Shlyakhto E.V. Epidemiologiya metabolicheskogo sindroma v razlichnykh rayonakh. Zavisimost' ot ispol'zuemykh kriteriev I prognostivcheskoe znachenie [Epidemiology of metabolic syndrome in different regions. The dependence on the criteria being used and the prognostic significance]. Arterial'naya gipertenziya 2007; 13: 2: 95-112. [In Russ.].
Isomaa B. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Eds. Tuomi et al. Diabet Care 2001; 24: 683-689.
Dekker М. Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study. Circulation 2005; 112: 666-673.
Laaka H.M. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
Droyvold W.B. Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway. J Int Obestet 2006; 30: 935-939.
Beer-Borst S. Obesity and other health determinants across Europe: the EURALIM project. Comm Health 2000; 54: 424-430.
Wareham N.J., Byrne et al. Cigarette smoking is not associated with hyperinsulinemia, evidence against a causal relationship between smoking and insulin resistance. Metabolism 1996; 45: 1551-1556.
Mohamed-Ali V. Association of proinsulin like molecules with lipids and fibrinogen in non diabetic subjects evidence against a modulating role for insulin. Diabetologia 1995; 38: 1110-1116.
Mancia G. Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: daily life blood pressure, cardiac damage and prognosis. Hypertension 2007; 49: 1: 40-47.
Ford E.S. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 3: 356-359.
Lorenzo D. The metabolic syndrome as predictor of type 2 diabetes in San-Antonio Heart Study. Diabet Care 2003; 26: 3153-3159.
Mitchell B.D. Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study. Obestet Res 2004; 12: 5: 831-839.
ARIC Investigators. The Atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
Caban A.J. Obesity in US Workers: The National Health Interview Survey, 1986 to 2002. Am J Public Health 2005; 95: 1614-1622.
Pambianco G. The Prediction of Major Outcomes of Type 1 Diabetes: A 12 year prospective evaluation of three separate definitions of the Metabolic Syndrome, and their components and estimated glucose disposal rate: The Pittsburgh Epidemiology of Diabetes Complications Study Experience. Orchard Diabet Care 2007; 30: 1248-1254.
Denker P.S. Fasting serum insulin levels in essential hypertension. A metaanalysis. Arch Intern Med 1992; 152: 8: 1649-1651.
Saad M.F. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991; 324: 11: 733-739.
Tan S.E. Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians? Diabet Care 2004; 27: 1182-1186.
Onat A. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285-292.
Sy R.G. Metabolic syndrome in Asia: time for action. Insights 2006; 9: 4-7.
Popkin B.M. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 2006; 84: 289-298.
Deepa R. Prevalence of insulin resistance syndrome in aselected south Indian population and the Chennai urban population study-7 (CUPS-7). Premalatha Indian J Med Res 2002; 115: 118-127.
Azizi F. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabet Res Clin Pract 2003; 61: 29-37.
Hwang L.C. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Ass 2006; 105: 626-635.
Park H.S. Prevalence of the metabolic syndrome among Korean adults according to criteria of IDF. Diabet Care 2006; 29: 933-934.
Kim E.S. Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 2004; 21: 1141-1143.
Ko G.T. High prevalence of metabolic syndrome in Hong Kong Chinese comparison of three diagnostic criteria. Diabet Res Clin Pract 2005; 69: 160-168.
Tanaka H. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006; 69: 369-374.
Thomas G.N. The US National Cholesterol Education Programme Adult Treatment Panel III prelevanse of the metabolic syndrome in a Chinese population. Diabet Res Clin Pract 2005; 67: 251-257.
Keldibaeva A.T. Rasprostranyonnost' metabolicheskogo sindroma I ego komponentov v gruppe etnicheskikh kyrgyzov [The prevalence of metabolic syndrome and its components in the group of ethnic Kirghiz]. Vestnik KGMA im. I.K. Akhunbaeva 2011; 1: 40-44. [In Russ.].
Cabrera M.A. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. Int J Cardiol 2007; 114: 224-229.
Rosenbaum P. Japanese-Brazilian Diabetes Study Group Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians. Diabet Obes Metabol 2005; 7: 352-359.
Simonova G.I. Rasprostranyonnost' metabolicheskogo sindroma I ego komponentov v Sibiri. Konferentsiya "Aktual'nye voprosy diagnostiki I lecheniya metabolicheskogo sindroma": Materialy [The prevalence of metabolic syndrome and its components in Siberia. Conference "The topical problems of the diagnostics and treatment of metabolic syndrome": Abstracts]. M 2006. [In Russ.].
Nikitin Yu.P. Rasprostranyonnost' metabolicheskogo sindroma X i ego komponentov v neorganizovannoy gorodskoy populyatsii (epidemiologicheskoe issledovanie) [The prevalence of metabolic syndrome X and its components in the random urban population (an epidemiological survey)]. Kardiologiya 2001; 9: 37-40. [In Russ.].
Rekomendatsii ekspertov Vserossiyskogo nauchnogo obshchestva kardiologov po diagnostike I lecheniyu metabolicheskogo sindroma. 2-y peresmotr. Vserossiyskoe nauchnoe obshchestvo kardiologov [Elektronny resurs] [The recommendations of the experts of the All-Russian scientific society of cardiologists on the diagnostics and treatment of metabolic syndrome. 2nd revision. All-Russian scientific society of cardiologists [Electronic resource]]. M 2009. [In Russ.].
Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 12: 1595-1607.
Rotar' O.P. Rasprostranyonnost' metabolicheskogo sindroma v raznykh gorodakh RF [The prevalence of metabolic syndrome in different cities of the Russian Federation]. Ros kardiol zhurn 2012; 2: 55-62. [In Russ.].
Kylbanova E.S. Izbytochnaya massa tela I ozhirenie sredi prishlogo naselenia Yakutii. Rossiysky natsional'ny congress kardiologov. Tezisy [The excess body weight and obesity among the alien population of Yakutiya. The Russian national congress of cardiologists: Abstracts]. M 2005. [In Russ.].
Argunov V.A. Osobennosti ateroskleroza koronarnykh arteriy u korennogo I prishlogo naseleniya g. Yakutsk [The peculiar features of coronary arteries atherosclerosis in the indigenous and alien residents of the city of Yakutsk]. Kardiovask ter I prof 2005; 4: 4: 21-22 (prolozhenie). [In Russ.].
Suplotova L.A. Rasprostranyonnost' izbytochnoy massy tela, ozhireniya, metabolicheskogo sindroma I ego komponentov v zhenskoy populyatsii Krainego Severa [The prevalence of excess body weight, obesity, metabolic syndrome, and its components in the female population of the Russian Far North]. Nauka I obrazov Urala 9: 6: 23-26. [In Russ.].
Suplotova L.A. Rasprostranyonnost' ozhireniya, patologicheskoy pribavki vesa tela I metabolicheskogo sindroma u zhenshchin Krainego Cevera pri beremennosti [The prevalence of obesity, pathological gain of body weight, and metabolic syndrome among the women in the Russian Far North during pregnancy]. Akush I ginekol 2011; 2: 77-81. [In Russ.].
Ogarkov M.Yu. Rasprostranyonnost' komponentov metabolicheskogo sindroma X u korennogo I nekorennogo naseleniya Gornoy Shorii [The prevalence of the components of metabolic syndrome X among the indigenous and alien populations of Mountain Shoriya]. Bul Sib otd Ros Akad med nauk 2004; 1: 108-111. [In Russ.].
Chazova I.E. Rasprostranyonnost' metabolicheskogo sindroma I otdel'nylh ego komponentov u patsientov s arterial'noy gipertenziey I ozhireniem [The prevalence of metabolic syndrome and its specific components among the patients presenting with arterial hypertension and obesity]. Kardiovask ter I prof 2005; 4: 6: 51-61. [In Russ.].
Profilaktika serdechno-sosudistykh zabolevaniy v detskom I podrostkovom vozraste: Rossiyskie rekomendatsii. Rossiyskoe kardologicheskoe obshchestvo. Rossiyskoe meditsinskoe obshchestvo po arterial'noy gipertonii. Assotsiatsiya detskikh kardiologov Rosii. Rossiyskoe obshchestvo kardiosomaticheskoy reabilitatsii I vtorichnoy profilaktiki [Prophylaxis of cardiovascular diseases in the children and adolescents. The Russian guidelines. Russian cardiological society. Russian medical society of arterial hypertension. Association of pediatric cardiologists of Russia. Russian society of cardiosomatic rehabilitation and secondary prophylaxis]. Ros kardiol zhurn 2012; 6: 98: 40 (prilozhenie). [In Russ.].
Zav'yalova L.G. Rasprostranyonnost' insulinorezistentnosti I eyo assotsiatsii s komponentami metabolicheskogo sindroma u podrostkov (po dannym populyatsionnogo issledovaniya) [The prevalence of insulin resistance and its association with the components of metabolic syndrome in the adolescents (based on the results of a population survey)]. Ros kardiol zhurn 2012; 4: 37-42. [In Russ.].
Avdeeva O. Rasprostranyonnost' metabolicheskogo sindroma sredi bol'nykh revmatologicheskogo profilya [The prevalence of metabolic syndrome among the patients suffering from rheumatic disorders]. Fundament issledov 2008; 2: 6. [In Russ.].
Sheptun P.A. Innovatsionnye podkhody k lecheniyu I profilaktike metabolicheskogo sindroma v ambulatornoy praktike. Avtoref. diss. … kand. med. nauk [The innovative approaches to the treatment and prevention of metabolic syndrome based at the outpatient facilities. Synopsis of the thesis for … candidate med. sci. degree]. Astrakhan 2011. [In Russ.].
Blagosklonnaya Ya.V. Ozhirenie I ego potentsial'naya rol' v razvitii metabolicheskogo syndroma [Obesity and its potential role in the development of metabolic syndrome]. Novye Sankt-Peterburg vrach vedom 1998; 4: 43-48. [In Russ.].
Simonova G.I. Epidemiologicheskie predposylki kontrolya narusheniy uglevodnogo obmena [The epidemiological prerequisites for the control over disturbances of carbohydrate metabolism]. Bol serdtsa I sosud 2009; 2. [In Russ.].
Donirova O. Rasprostranyonnost' komponentov metabolicheskogo sindroma sredi bol'nykh pozhilogo vozrasta [The prevalence of the components of metabolic syndrome among the aged patients]. Vestn buryat un-ta 2009; 12: 111-114. [In Russ.].
Iribarren C. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts? J Am Coll Cardiol 2006; 48: 9: 1800-1807.
Obshcherossiyskaya obshchestvennaya organizatsiya sodeistviya profilaktike I lecheniyu arterial'noy gipertonii "Antigipertenzivnaya liga". Protokol "Natsional'noe issledovanie riska serdechno-sosudistykh oslozhneniy pri metabolicheskom sindrome" www.ahleague.ru/index.php?option=com_content&view=article&id=121&Itemid=115&lang=ru [The All-Russian public organization for the promotion of prophylaxis and treatment of arterial hypertension "Antihypertensive League". Protocol "The national survey of the risk of cardiovascular complications of metabolic syndrome" " www.ahleague.ru/index. php?option=com_content&view=article&id=121&Itemid=115&lang=ru [In Russ.].
Mitrofanov I.M. Rasprostranyonnost' metabolicheskogo sindroma v organizovannoy populyatsii [The prevalence of metabolic syndrome among the organized population]. Klin med 2012; 90: 11: 47-50. [In Russ.].

Close metadata